International Cannabis Weekly: 341

PRESIDENT BIDEN BACKS CANNABIS POLICY REFORM IN STATE OF THE UNION ADDRESS

For the first time ever, the president of the United States backed cannabis policy reform during his State of the Union address.

READ MORE  »

CZECH PRESIDENT CALLS FOR REGULATED ACCESS TO LEGAL CANNABIS

READ MORE »

‘80% CHANCE’ CANNABIS RESCHEDULING DECISION WILL BE MADE IN COMING MONTHS

READ MORE »

• Authorities in France confirm flower will not be included in the country’s medical cannabis programme.
• UK’s illicit cannabis market estimated at £2.6 billion as demand for pain relief medication soars.
• Wana Brands, one of the largest North American cannabis edibles brands, is set to launch in Europe.
• UK industry urged to take action as medical cannabis supply issues endanger children’s lives.
• Aurora Cannabis executive optimistic about company’s position in Germany, advocates for medical market expansion.
• SOMAÍ Pharmaceuticals enters the UK market through distribution agreement with Grow Pharma.

READ STOCKS REPORT »

• Curaleaf grew annual revenue by 6% to $1.35 billion in 2023 and reduced its annual net loss.
• Washington State to waive excise taxes on medical marijuana products, offering relief to patients.
• Virginia legislative session draws to a close without governor signing adult-use cannabis bill.
• California dominates national hemp flower acreage and production in 2022, USDA Census of Agriculture reveals.
• Minnesota considers opening one of the first government-run cannabis dispensaries in the United States.
• Health & Wellness Firm B-Corp acquires cannabis patents valued at US$122 million.

GET TICKETS »

• Tax breaks for alcohol industry spark calls for equality from Canadian cannabis business leaders.
• Cannabis legalisation leads to a reduction in retail sales of beer, according to new data.
• Aqualitas has signed an agreement to merge with Cannaray Limited, a UK-based medical cannabis company.
• Allied Corp. signs agreement to supply major international manufacturer with 180kgs of THC and CBD flower.
• Fire and Flower moves its operations to Edmonton due to private bricks-and-mortar retail model.
• Manitobans opt for cannabis over alcohol, with recreational sales surging 23% in 2022/2023 fiscal year.

• Medicinal cannabis will be available via the São Paulo public health system within 45 days.
• Guyana’s Ministry of Agriculture prepares rules for hemp production with stakeholders reporting progress.
• Judicial victory ensures state-provided cannabidiol medicine for patients in Brazil.
• CannaPharmaRx, Inc. secures supply agreement with ICAN Green S.A. de C.V. for cannabis distribution in Latin America.

• Wimbledon Champion Pat Cash unveils CBD product line, hailing it as a ‘gamechanger’ for athletes.
• Malaysian MP, Ramkarpal Singh, calls for reform of drug laws to shift focus towards medical care.
• Avecho Biotechnology gains ethics approval for Phase III clinical trial of low-dose CBD capsule for insomnia.
• Aether Pacific makes first foray into Australian market with NZ-grown medicinal cannabis products.

• Amid high demand, medical cannabis experts hail ‘game-changing’ relaxation of rules in Israel.
• Mosh Ben Ari launches a new cannabis, with the strains named after his famous songs.